ProShare Advisors LLC - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 46 filers reported holding NEOS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$76,000
-23.2%
15,568
-1.7%
0.00%0.0%
Q2 2018$99,000
-28.3%
15,833
-4.5%
0.00%0.0%
Q1 2018$138,000
-29.9%
16,571
-14.1%
0.00%0.0%
Q4 2017$197,000
+159.2%
19,295
+67.9%
0.00%0.0%
Q3 2016$76,000
-39.7%
11,490
-15.7%
0.00%
-50.0%
Q2 2016$126,000
-6.0%
13,622
+10.0%
0.00%0.0%
Q1 2016$134,000
-31.3%
12,389
-9.1%
0.00%0.0%
Q4 2015$195,00013,6230.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,511,504$11,775,0006.77%
Broadfin Capital, LLC 1,611,999$4,207,0000.87%
Proxima Capital Management, LLC 206,000$538,0000.59%
SPHERA FUNDS MANAGEMENT LTD. 2,201,697$5,746,0000.52%
Nantahala Capital Management 4,485,000$11,706,0000.36%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,799,141$4,696,0000.18%
Wealthstar Advisors, LLC 73,295$192,0000.12%
Spark Investment Management LLC 303,258$791,0000.04%
Allred Capital Management, LLC 24,995$63,0000.04%
Livingston Group Asset Management CO (operating as Southport Capital Management) 24,000$63,0000.03%
View complete list of NEOS THERAPEUTICS INC shareholders